9/12 5:30 pm - 8:30 pm
HBA presents 'Putting Academia-Industry Research Partnerships to Work.' Novartis, 1 Health Plaza, East Hanover, NJ more
9/24 4:00 pm - 6:00 pm
CURE presents healthcare investment banker Anthony Gibney of Leerink Swann. Yale Anlyan Center, 300 Cedar Street, New Haven more
10/1 4:00 pm - 6:00 pm
CURE/Yale BioHaven presents Trevi Therapeutics. Anlyan Center, 300 Cedar Street, New Haven. Watch for details.
10/8-9 12th annual BIO Investor Forum. The Palace Hotel, San Francisco more
10/15 6:00 pm - 9:30 pm
HBA presents Women's Healthcare Innovation and Leadership Showcase. Sanofi Campus, 55 Corporate Drive Auditorium, Bridgewater, NJ more
11/7 10:00 am - 3:00 pm
CT Innovation Summit. Mentor meetings, awards ceremony, and more. Co-sponsored by CURE. Oakdale Theater, Wallingford more
11/11-13 The BIO Convention in China. National Convention Center, Beijing more
12/3 5:45 pm - 7:30 pm
CURE Holiday Party. 'The best networking in town.' Café George, 300 George Street, New Haven. Save the Date!

Cost-saving discounts for CURE members!
CURE members can now receive discounts on various products and services, such as lab supplies, shipping services, and gases more


HLK Biotechnology, Ltd.
10 Gaoxin Central 1st Ave
Bio-incubator, Suite 1-303
Nanshan District, Shenzhen , Guangdong Province, P.R. China Post Code 51807

Phone: 86-755-8600-7001
Fax: 86-755-8615-6677
Website: http://www.hlkpharma.com

Contact(s)
jun.xu@hlkpharma.com

General Information
HLK Biotechnology is a Chinese company founded by two pharma-experienced, US academically trained scientists. HLK is a portal for western companies or entrepreneurs to develop pharmaceuticals for the China market. We provide on the ground technical resources and project management for CMC and pre-clinical development. In addition, we are open to in-licensing or joint development of products. Most critical, is our attention to navigating the hurtles of doing business in China with regard to protecting IP, working with governmental agencies, universities, pharmaceutical/biotech companies, CROs, CMOs and regulators. As American citizens, with residency in Connecticut, we understand that entering the rapidly developing Chinese pharmaceutical market can be daunting. We are flexible in work style and offer strong communication connectivity to the US. Our goal is to bridge the best of the West with the East to bring efficacious and safe medicines to patients.

HLK is conveniently located in the High-Tech Industrial Zone of Shenzhen, Guangdong Province, China. Shenzhen is one of the top four major cities in China and is neighboring next to Hong Kong.

Other Information
World Employees: 6

Back